|
|
|
0 members (),
2,958
guests, and
25
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
1
|
2
|
3
|
4
|
5
|
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
|
27
|
28
|
29
|
30
|
|
|
|
|
There are no members with birthdays on this day. |
World Earthquake Report for Thursday, 24 September 2026
• Moderate mag. 4.3 earthquake - Madagascar: Mozambique Channel on Thursday, ...
• Small magnitude 3.9 earthquake hits near Hastings, Hastings District, Hawke...
• Volcano earthquake report for Thursday, 24 September 2026
• Light mag. 3.9 earthquake - South Pacific Ocean, 10.2 km south of Hastings,...
• Moderate magnitude 4.1 quake hits 31 miles southeast of Midland, Texas, Uni...
|
#571425
Mon 20 Jul 2020 06:59:PM
|
Joined: Feb 2001
Posts: 678,977
Launch Director
|
|
Launch Director
Joined: Feb 2001
Posts: 678,977 |
A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization. These antibodies potently neutralize the virus in young and old animals. The antibody levels induced are comparable to those in recovered COVID-19 patients. This formulation is shelf-stable, with mass-production and distribution advantages. Source: COVID-19 replicating RNA vaccine has robust response in nonhuman primates
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
|
Forums60
Topics840,728
Posts875,523
Members2,960
| |
Most Online102,106
Jul 10th, 2026
|
|
|
|
|
|
